GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Natus Medical Inc (NAS:NTUS) » Definitions » PE Ratio without NRI

Natus Medical (Natus Medical) PE Ratio without NRI : 89.08 (As of Apr. 26, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Natus Medical PE Ratio without NRI?

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2024-04-26), Natus Medical's share price is $32.96. Natus Medical's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2022 was $0.37. Therefore, Natus Medical's PE Ratio without NRI for today is 89.08.

Natus Medical's EPS without NRI for the three months ended in Mar. 2022 was $0.06. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2022 was $0.37.

As of today (2024-04-26), Natus Medical's share price is $32.96. Natus Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was $0.37. Therefore, Natus Medical's PE Ratio for today is 89.08.

Natus Medical's EPS (Diluted) for the three months ended in Mar. 2022 was $0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was $0.37.

Natus Medical's EPS (Basic) for the three months ended in Mar. 2022 was $0.06. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2022 was $0.38.


Natus Medical PE Ratio without NRI Historical Data

The historical data trend for Natus Medical's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natus Medical PE Ratio without NRI Chart

Natus Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss 60.85

Natus Medical Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss 649.50 52.25 60.85 71.03

Competitive Comparison of Natus Medical's PE Ratio without NRI

For the Medical Devices subindustry, Natus Medical's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natus Medical's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Natus Medical's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Natus Medical's PE Ratio without NRI falls into.



Natus Medical PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Natus Medical's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=32.96/0.370
=89.08

Natus Medical's Share Price of today is $32.96.
Natus Medical's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.37.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Natus Medical  (NAS:NTUS) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Natus Medical PE Ratio without NRI Related Terms

Thank you for viewing the detailed overview of Natus Medical's PE Ratio without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Natus Medical (Natus Medical) Business Description

Traded in Other Exchanges
N/A
Address
3150 Pleasant View Road, Middleton, WI, USA, 53562
Natus Medical Inc is a provider of newborn care, neurology, and hearing and balance assessment healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. It is divided into three business units: Neuro, Newborn Care, and Hearing and Balance. The company generates a majority of its revenue from the Neurology business unit which includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care, and neurosurgery.
Executives
Chung Dong Chune Christopher officer: Vice President Medical Affairs 1501 INDUSTRIAL ROAD SAN CARLOS CA 94070
Bryant M Moore director 181 HARVEST LANE PITTSBORO NC 27312
Eric Guerin director 1950 HASSELL ROAD, HOFFMAN ESTATES IL 60169
Ilan Daskal director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Alice D. Schroeder director 1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Lisa Wipperman Heine director 1244 76TH STREET WEST, INVER GROVE HEIGHTS MN 55077
Jonathan Kennedy director, officer: Sr. VP, CFO INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Ken Ludlum director
Robert A Gunst director
Noll Austin Francis Iii officer: VP/GM Neurology 9805 FALLEN LEAF DRIVE MIDDLETON WI 53562
Thomas Joseph Sullivan director 64 PETTIT PL PRINCETON NJ 08540
Benjamin Drew Davies officer: Sr. VP, CFO 1501 INDUSTRIAL ROAD, SAN CARLOS X1 94070
Joshua Levine director 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Sharon Villaverde officer: Interim CFO 11780 U.S. HIGHWAY 1, SUITE 600, PALM BEACH GARDENS FL 33408
William M Moore director